Hemangiosarcoma in Dogs: The Silent Cancer Owners Need to Understand

If you have never heard of hemangiosarcoma, you are in the majority. Most owners meet the word for the first time in an emergency room, at the worst possible hour, when a dog who seemed completely fine that morning has suddenly collapsed. That is the defining cruelty of this cancer, and it is why a Morris Animal Foundation white paper on the disease opens by describing a cancer that strikes without warning. Reading about it in advance will not prevent it. It does mean that if you ever hear the word, you will not be hearing it cold.

What hemangiosarcoma actually is

Hemangiosarcoma is a cancer of the cells that line blood vessels. Because those cells exist everywhere blood goes, the tumours tend to set up in organs with a rich blood supply, and the Foundation's paper names the spleen and the heart in particular. A tumour built out of blood vessel tissue is a fragile thing. It fills with blood, and it can tear. When it does, the dog bleeds internally and fast, which is why the paper describes sudden rupture, massive bleeding and collapse as the classic way this disease introduces itself.

That also explains why so many diagnoses happen at an emergency clinic rather than a routine check-up. The Foundation notes that the vast majority of hemangiosarcomas are found on emergency visits, which leaves everyone involved, owner and veterinarian alike, making enormous decisions in a hurry and with very little information.

How common is it, and in which dogs

In the Foundation's figures, hemangiosarcoma accounts for about 3% of all canine tumours. That is not the most common cancer dogs get, but it is a meaningful slice, and it is not spread evenly across breeds. The paper names golden retrievers, Portuguese water dogs, German shepherds and Labrador retrievers among the breeds it commonly affects, and states that one in five golden retrievers will be diagnosed with the disease.

That golden retriever figure is a lifetime risk, and it is worth putting beside a published analysis of the Foundation's own Golden Retriever Lifetime Study, a project following more than 3,000 goldens across their whole lives. In that analysis, 233 of 3,044 dogs, or 7.65%, had been diagnosed at the point the data was examined. Those dogs are still being followed, so that number is not final. The same analysis found that most cases were visceral, meaning inside the body, with the spleen and heart the usual sites, and that the probability of a dog remaining unaffected began to fall from around four years of age.

• The tumours favour organs with a rich blood supply, especially the spleen and the heart.
• Golden retrievers, Portuguese water dogs, German shepherds and Labrador retrievers are among the breeds affected more often.
• Most cases are internal, though a form also occurs in the skin.
• Most diagnoses are made during an emergency, not at a routine appointment.

The honest picture on treatment

Here the Foundation is very direct, and it would be unkind to soften it. These tumours are true medical emergencies, and many dogs need immediate surgery to remove the bleeding mass where that is possible, followed by supportive care simply to survive the crisis. Surgery, the paper says plainly, is rarely curative and is sometimes not even an option.

The survival figures it reports are these. An average of one to three months with surgery alone. Five to seven months with surgery and chemotherapy together. Around 90% of dogs die within a year of diagnosis despite both. The Foundation also makes a point that ought to make the research world uncomfortable: despite thirty years of progress in canine oncology generally, survival statistics for this particular cancer have not meaningfully changed in twenty. Chemotherapy resistance is part of the reason. Many hemangiosarcomas respond at first and then stop responding, and the cancer grows and spreads again.

What research is trying to change

The Foundation has funded hemangiosarcoma research for more than 25 years and invested over three million dollars in it. In September 2022 it announced a new multi-year, multi-million-dollar initiative aimed specifically at the prevention, detection and treatment of this cancer, with the first projects due to start in late 2023. Its stated priorities are worth knowing, because they map neatly onto what owners actually need.

The first is earlier detection. Almost everything that is bad about hemangiosarcoma follows from the fact that it is usually found on the day it ruptures. Hemangiosarcoma is a primary endpoint of the Golden Retriever Lifetime Study, and the Foundation is banking samples from affected dogs in that cohort, including samples collected years before diagnosis, in the hope that researchers can build an early diagnostic test and identify genetic risk factors. Genetic findings in one breed, it notes, often make it easier to assess risk in other breeds and in mixed-breed dogs too.

The second is metastasis and drug resistance: understanding how this cancer spreads, and how it slips out from under chemotherapy. The paper is candid that this work is expensive, with a single veterinary clinical trial easily passing a million dollars, and that because hemangiosarcoma is essentially a dog problem there is very little federal or state funding for it. That gap gets filled by non-profits and donors, or it does not get filled.

What this means for you and your dog

Very little of this is actionable in the way owners want health information to be actionable, and pretending otherwise would be dishonest. There is no screening test yet. There is no diet or supplement shown to prevent it. What is reasonable is narrower: know that sudden collapse in a middle-aged or older dog is an emergency and behave accordingly, have new skin lumps checked, and if you have a golden retriever, hold the higher breed risk lightly rather than letting it colour every ordinary happy year in between.

And if you are reading this because a veterinarian has already said the word to you, the most useful thing this paper offers is context rather than comfort. The odds are genuinely poor, the decisions are genuinely hard, and none of it reflects something you failed to spot. This cancer hides on purpose, and it hid from your vet too.

This article explains published research and is educational only. It is not a substitute for diagnosis or treatment advice from a licensed veterinarian who has actually examined your dog.